ROYAL BANK OF CANADA - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$111,000
-75.1%
4,637
-84.8%
0.00%
Q4 2020$445,000
+8800.0%
30,507
+8742.6%
0.00%
Q3 2020$5,000
-28.6%
345
-24.8%
0.00%
Q2 2020$7,000
+600.0%
459
+57.2%
0.00%
Q1 2020$1,000
-87.5%
292
-82.9%
0.00%
Q4 2019$8,0001,710
+42650.0%
0.00%
Q3 2019$0
-100.0%
4
-98.9%
0.00%
Q2 2019$2,000377
+9325.0%
0.00%
Q1 2019$040.0%0.00%
Q4 2018$0
-100.0%
4
-99.6%
0.00%
Q3 2018$8,0001,041
+1606.6%
0.00%
Q2 2018$061
+1425.0%
0.00%
Q1 2018$0
-100.0%
4
-98.9%
0.00%
Q4 2017$2,000
-95.1%
375
-91.2%
0.00%
Q3 2017$41,000
+4000.0%
4,283
+3439.7%
0.00%
Q2 2017$1,000
-94.7%
121
-91.9%
0.00%
Q1 2017$19,000
-61.2%
1,485
-62.4%
0.00%
Q4 2016$49,000
+206.2%
3,952
+189.7%
0.00%
Q3 2016$16,000
+33.3%
1,364
+0.6%
0.00%
Q2 2016$12,000
+71.4%
1,356
+6.3%
0.00%
Q1 2016$7,000
-36.4%
1,276
-6.7%
0.00%
Q4 2015$11,000
-54.2%
1,367
-55.1%
0.00%
Q3 2015$24,000
-29.4%
3,047
-16.7%
0.00%
Q2 2015$34,000
+100.0%
3,659
+186.8%
0.00%
Q1 2015$17,0000.0%1,2760.0%0.00%
Q4 2014$17,0001,2760.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders